Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis - 05/08/24

Doi : 10.1016/j.jaci.2024.04.025

Hiroki Sato, MD, PhD ^a, Evan S. Dellon, MD, MPH ^b, Seema S. Aceves, MD, PhD ^c, Nicoleta C. Arva, MD, PhD ^d, Mirna Chehade, MD, MPH ^e, Margaret H. Collins, MD ^a, Carla M. Davis, MD ^f, Gary W. Falk, MD, MS, MASGE ^g, Glenn T. Furuta, MD ^h, Nirmala P. Gonsalves, MD ⁱ, Sandeep K. Gupta, MD ^j, Ikuo Hirano, MD ⁱ, Girish Hiremath, MD, MPH ^k, David A. Katzka, MD ^l, Paneez Khoury, MD, MHSc ^m, John Leung, MD ⁿ, Paul Menard-Katcher, MD ^o, Robbie Pesek, MD ^p, Kathryn A. Peterson, MD ^q, Maria A. Pletneva, MD, PhD ^q, Jonathan M. Spergel, MD, PhD ^r, Joshua B. Wechsler, MD, MS ^s, Guang-Yu Yang, MD ⁱ, Marc E. Rothenberg, MD, PhD ^a,^t, Tetsuo Shoda, MD, PhD ^a,^t,^⁎
^a Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
^b University of North Carolina, Chapel Hill, NC
^c University of California San Diego School of Medicine, San Diego, Rady Children’s Hospital, San Diego, Calif
^d Nationwide Children’s Hospital, Columbus, Ohio
^e Icahn School of Medicine at Mount Sinai, New York, NY
^f Baylor College of Medicine, Texas Children’s Hospital, Houston, Tex
^g Penn Medicine, Philadelphia, Pa
^h Children’s Hospital Colorado, Aurora, Colo
ⁱ Northwestern University Feinberg School of Medicine, Chicago, Ill
^j University of Alabama at Birmingham, Birmingham, Ala
^k Vanderbilt University Medical Center, Nashville, Tenn
^l Columbia University Irving Medical Center, New York, NY
^m National Institutes of Health, Bethesda, Md
ⁿ Boston Specialists, Boston, Mass
^o University of Colorado Anschutz Medical Campus, Aurora, Colo
^p University of Arkansas for Medical Science, Little Rock, Ark
^q University of Utah Health, Salt Lake City, Utah
^r Children’s Hospital of Philadelphia, Philadelphia, Pa
^s Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Ill
^t University of Cincinnati College of Medicine, Cincinnati, Ohio

^∗Corresponding author: Tetsuo Shoda, MD, PhD, Division of Allergy and Immunology, Cincinnati Children’s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine: 3333 Burnet Ave, ML 7028, Cincinnati, OH 45229.Division of Allergy and ImmunologyCincinnati Children’s Hospital Medical CenterDepartment of PediatricsUniversity of Cincinnati College of Medicine: 3333 Burnet AveML 7028CincinnatiOH45229

Graphical abstract

Le texte complet de cet article est disponible en PDF.

Abstract

Background

The Index of Severity for Eosinophilic Esophagitis (I-SEE) is a new expert-defined clinical tool that classifies disease severity of eosinophilic esophagitis (EoE).

Objective

We aimed to determine whether I-SEE is associated with patient characteristics, molecular features of EoE, or both.

Methods

We analyzed a prospective cohort of patients with EoE from the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). Associations between I-SEE and clinical and molecular features (assessed by an EoE diagnostic panel [EDP]) were assessed.

Results

In 318 patients with chronic EoE (209 adults, 109 children), median total I-SEE score was 7.0, with a higher symptoms and complications score in children than adults (4.0 vs 1.0; P < .001) and higher inflammatory and fibrostenotic features scores in adults than children (3.0 vs 1.0 and 3.0 vs 0, respectively; both P < .001). Total I-SEE score had a bimodal distribution with the inactive to moderate categories and severe category. EDP score correlated with total I-SEE score (r = −0.352, P < .001) and both inflammatory and fibrostenotic features scores (r = −0.665, P < .001; r = −0.446, P < .001, respectively), but not with symptoms and complications scores (r = 0.047, P = .408). Molecular severity increased from inactive to mild and moderate, but not severe, categories. Longitudinal changes of modified I-SEE scores and inflammatory and fibrostenotic features scores reflected histologic and molecular activity.

Conclusions

I-SEE score is associated with select clinical features across severity categories and with EoE molecular features for nonsevere categories, warranting further validation.

Le texte complet de cet article est disponible en PDF.

Key words : Eosinophilic esophagitis, diagnostic panel, eosinophil, complications, outcome

Abbreviations used : CEGIR, EDP, EGID, EoE, eos/hpf, FDR, IQR, I-SEE, m-I-SEE, OMEGA

Plan

Methods

Study design and data source

Correlation between patient characteristics, molecular profiles, and I-SEE

Longitudinal analyses of I-SEE

Statistical analyses

Results

I-SEE scores and domain distribution

Molecular correlates of I-SEE scores

Longitudinal assessment of severity

Discussion

Export

Vol 154 - N° 2

P. 375 - août 2024 Retour au numéro

Article précédent

Staphylococcus aureus–specific skin resident memory T cells protect against bacteria colonization but exacerbate atopic dermatitis–like flares in mice
Camille Braun, Cédric Badiou, Aurélie Guironnet-Paquet, Masashi Iwata, Vanina Lenief, Amandine Mosnier, Charlotte Beauclair, Emilie Renucci, Pauline Bouschon, Roxane Cuzin, Yoann Briend, Vijaykumar Patra, Sabine Patot, Tiffany C. Scharschmidt, Willem van Wamel, Nicole Lemmens, Saeko Nakajima, François Vandenesh, Jean-François Nicolas, Gérard Lina, Audrey Nosbaum, Marc Vocanson

| Article suivant

A mutation in Themis contributes to anaphylaxis severity following oral peanut challenge in CC027 mice
Ellen L. Risemberg, Johanna M. Smeekens, Marta C. Cruz Cisneros, Brea K. Hampton, Pablo Hock, Colton L. Linnertz, Darla R. Miller, Kelly Orgel, Ginger D. Shaw, Fernando Pardo Manuel de Villena, A. Wesley Burks, William Valdar, Michael D. Kulis, Martin T. Ferris

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis - 05/08/24

Graphical abstract

Abstract

Background

Objective

Methods

Results

Conclusions

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL